Abbott Laboratories vs. Adial Pharmaceuticals, Inc
Abbott Laboratories and Adial Pharmaceuticals, Inc are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | ADIL | |
|---|---|---|
| Market Cap | $181.50 billion | $10.62 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | ADIL | |
|---|---|---|
| Dividend Yield | 2.42% | — |
ABT and ADIL split the dividend factors evenly.
Risk & Sentiment
| ABT | ADIL | |
|---|---|---|
| Short Interest | 0.57% | 0.00% |
ADIL leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ADIL overview, ADIL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.